EPISODE · Apr 21, 2026 · 19 MIN
Danaher Corporation First Quarter 2026 Financial Results and Form 10-Q
from Daily Market Download · host Daily Market Download
These documents primarily consist of a quarterly financial report (Form 10-Q) filed with the Securities and Exchange Commission for the period ending March 27, 2026. The records detail the financial performance and operational health of Danaher Corporation, showcasing growth in net earnings and sales across its biotechnology, life sciences, and diagnostics segments. A significant highlight includes the company's $9.9 billion definitive agreement to acquire Masimo Corporation, a specialty diagnostics provider. The sources also outline the firm's debt structure, tax obligations, and the establishment of a $5.0 billion credit facility to support future liquidity and acquisition funding. Additionally, the initial text includes a brief security verification notice from the financial website MarketBeat.
What this episode covers
These documents primarily consist of a quarterly financial report (Form 10-Q) filed with the Securities and Exchange Commission for the period ending March 27, 2026. The records detail the financial performance and operational health of Danaher Corporation, showcasing growth in net earnings and sales across its biotechnology, life sciences, and diagnostics segments. A significant highlight includes the company's $9.9 billion definitive agreement to acquire Masimo Corporation, a specialty diagnostics provider. The sources also outline the firm's debt structure, tax obligations, and the establishment of a $5.0 billion credit facility to support future liquidity and acquisition funding. Additionally, the initial text includes a brief security verification notice from the financial website MarketBeat.
NOW PLAYING
Danaher Corporation First Quarter 2026 Financial Results and Form 10-Q
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m